Sort   by:  
 Page size 
UnknownDurable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Not available
S-EPMC11103095 | biostudies-literature
UnknownEfficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.
Not available
S-EPMC7489405 | biostudies-literature
UnknownGenome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.
Not available
S-EPMC4185120 | biostudies-literature
UnknownDe novo and inherited dominant variants in U4 and U6 snRNAs cause retinitis pigmentosa.
Not available
S-EPMC11741465 | biostudies-literature
UnknownA simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
Not available
S-EPMC10410129 | biostudies-literature
UnknownOutcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study.
Not available
S-EPMC8570701 | biostudies-literature
UnknownImplementation of Recommendations on the Use of Corticosteroids in Severe COVID-19.
Not available
S-EPMC10751594 | biostudies-literature
UnknownLarge-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.
Not available
S-EPMC10942532 | biostudies-literature
UnknownIdentification of six new susceptibility loci for invasive epithelial ovarian cancer.
Not available
S-EPMC4445140 | biostudies-literature
UnknownAssociation Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
Not available
S-EPMC8524310 | biostudies-literature
Sort   by:  
 Page size